GridelliC., PerroneF., MonfardiniS.: Lung cancer in the elderly. Eur J Cancer, 33: 2313–2314, 1997.
2.
HavlikR.J., YancikR., LongS.: The National Cancer Institute on Aging and the National Cancer Institute SEER. Collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer, 74: 2101–2106, 1994.
3.
FentimanI.S., TirelliV., MonfardiniS.: Cancer in the elderly: why so badly treated?Lancet, 28: 1020–1022, 1990.
4.
GridelliC.: Chemotherapy of advanced non small cell lung cancer in the elderly: an update. Crit Rev Oncol Hematol, 35: 219–225, 2000.
5.
Non-small Cell Lung Cancer Collaborative Group:Chemotherapy in non small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J, 311: 899–909, 1995
6.
GridelliC., PerroneF., GalloC.: Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non smalll cell lung cancer. A two-stage phase II study. Eur J Cancer, 33: 392–397, 1997.
7.
The Elderly Lung cancer Vinorelbine Italian Study group:Effect of vinorelbine on quality of life and survival of elderly patients with advanced non small cell lung cancer. J Natl Cancer Inst, 91: 66–72, 1999.
8.
GridelliC., CigolariS., PerroneF.: Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non small cell lung cancer elderly patients: a phase II data from Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial. Lung Cancer, 31: 277–284, 2001.
9.
FidiasP., SupkoJ., BoralA.: A phase II clinical and pharmacokinetic study of weekly paclitaxel in elderly patients with non small cell lung cancer. Lung Cancer, 29: 119, 2000.
10.
HainsworthJ.D., BurrisH.A., LitchyS.: Weekly docetaxel in the treatment of elderly patients with advanced non small cell lung carcinoma. Cancer, 89: 328–233, 2000.
11.
RinaldiM., De MarinisF., ArdizzoniA.: Correlation between age and prognosis in patients with advanced non small cell lung cancer (NSCLC) treated with cisplatin (CDDP) containing chemotherapy: a retrospective multicenter study. Ann Oncol, 5, 58, 1994.
12.
BerettaG.D., MichettiG., BelomettiM.O.: Gemcitabine plus vinorelbine in elderly or unfit patients with non small cell lung cancer. Br J Cancer, 83: 573–576, 2000.
13.
McKayC.III, HainsworthJ., BurrisH.III: Weekly docetaxel/gemcitabine in the treatment of elderly patients with advanced non small cell lung cancer: a Minnie Pearl Cancer Research phase II trial. Proc ASCO, 20: 260b, 2001.
14.
GridelliC., PerroneF., CigolariS.: The MILES (Multicenter Italian Lung Cancer in the Elderly Study) phase 3 trial: gemcitabine + vinorelbine vs vinorelbine and vs gemcitabine in elderly advanced NSCLC patients. Proc ASCO, 20: 308a, 2001.
